Sweden, FranceFrance

Cellectis buys Cellartis

16.09.2011

Paris – For €16.4m in cash and roughly €12m in shares, French genome engineering specialist Cellectis has taken over Swedish Cellartis. Cellartis is the European leader in stem cell-derived cardiomyocytes and hepatocytes. With 62 employees, it earned €3.8m in 2010." The acquisition of Cellartis will enable Cellectis to gain a leadership position in the very promising field of stem cells", said Thomas Devedjian, Director and Member of the Executive Committee of the FSI. The FSI or Strategic Investment Fund, is a strategic investment tool of the French State. Together with private investor Pierre Bastid, the FSI will cough up €50m to finance the move. Cellectis wants to become the world leader in stem cell-derived in vitro R&D tools and related technologies. Cellartics value for Celelctis is based on two main pillars. The Swedes own the largest stem cell bank in the world (30 proprietary lines) and in 10 years have built a considerable expertise and two certified production sites in Sweden and Scotland. The second pillar is the research collaborations with partners like Novo Nordisk and the French Blood Agency.

FranceFrance

10.06.2011

Paris/Berlin – Germany and France are establishing a new form of cross-border cooperation in the life sciences. The French public health research institute Inserm and the German Helmholtz Association have agreed to build up joint...

FranceFrance

10.05.2011

Pomacle/Paris/Minneapolis – French/US firm BioAmber Inc. has raised US$45 million dollars in a Series B financing led by Paris-based private equity firm NAXOS Capital Partners and with participation of BioAmber's largest...

FranceFrance

02.05.2011

Paris - Sanofi-Aventis was reminded that steady income flows in the pharma buisness are a thing of the past. The French drugmaker saw its earnings fall by nearly 30 percent in the first quarter, as low swine flu vaccine sales...

FranceFrance

21.04.2011

Sophia Antipolis – French nitric oxide-donating drug specialist NicOx S.A. has withdrawn the EU Marketing Authorization Application (MAA) for ist osteoarthritis candidate naproxcinod (Beprana) after a meeting of the European...

FranceFrance

10.04.2011

Paris – French researchers under Etienne Hirsch from the Pasteur University in Paris have discovered that glucocorticoid receptors (GR) play a pivotal role in inflammation-mediated damage of dopaminergic neurons in the course of...

FranceFrance

04.04.2011

Toulouse – Three French research clusters have earmarked EUR20 million to build a pre-industrial demonstration plant in the area of white biotechnology. The new facility, will test the feasibility of industrial production of 2nd...

FranceFrance

01.04.2011

Toulouse – Three French research clusters have earmarked EUR20m to build a pre-industrial demonstration plant in the area of white biotechnology. The new facility, named Toulouse White Biotech­nology (TWB), will test the...

FranceFrance

01.04.2011

Lyon – Fuelled by governmental support, the French biotech sector experienced a vintage year in 2010, with a second generation of companies now emerging. But according to the Life Science Panorama 2010 survey, released by the...

FranceFrance

18.03.2011

Lille – Biopharmaceutical company Genfit has signed a deal with drug giant Sanofi-Aventis to discover molecules to correct mitochondrial dysfunction associated with metabolic disease. Sanofi will have exclusive worldwide rights...

Displaying results 31 to 40 out of 268

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/3/article/cellectis-buys-cellartis.html

Product of the week

Products

Events

All Events

Current issue

All issues